ISSN 1662-4009 (online)

ey0017.13-15 | Endocrinology | ESPEYB17

13.15. Adverse outcomes and economic burden of congenital adrenal hyperplasia late diagnosis in the newborn screening absence

de Miranda M Costa , Haddad L Bertocco de Paiva , G Madureira , B Bilharinho de Mendonca , TASS Bachega

To read the full abstract: J Endocrine Society 2020; 4 (2): 1–13. doi: 10.1210/jendso/bvz013• The authors performed a retrospective analysis of the economic burden in a cohort of 195 patients with genetically confirmed CAH born in São Paulo where there is presently no neonatal screening for CAH.• The cost associated to mortality of undiagnosed patients was estimated to ra...

ey0019.8-7 | Important for Clinical Practice | ESPEYB19

8.7. Low adrenomedullary function predicts acute illness in infants with classical Congenital Adrenal Hyperplasia

J Weber , VK Tanawattanacharoen , A Seagroves , MC Liang , CM Koppin , HM Ross , TASS Bachega , ME Geffner , M Serrano-Gonzalez , G Bhullar , MS Kim

J Clin Endocrinol Metab. 2022; 107(1): e264–e271. PMID: 34397083https://pubmed.ncbi.nlm.nih.gov/34397083/ Brief Summary: This prospective cohort study determined plasma epinephrine concentrations in infants with classic CAH, and showed that the lower epinephrine reseve is associated with increased risk of illness.Children and adolescents with classical Congenital ...

ey0017.8-17 | Food for Thought | ESPEYB17

8.17. Plasma renin measurements are unrelated to mineralocorticoid replacement dose in patients with primary adrenal insufficiency

R Pofi , A Prete , V Thornton-Jones , J Bryce , SR Ali , Ahmed S Faisal , A Balsamo , F Baronio , A Cannuccia , A Guven , T Guran , F Darendeliler , C Higham , W Bonfig , L de Vries , TASS Bachega , MC Miranda , BB Mendonca , V Iotova , M Korbonits , NP Krone , R Krone , A Lenzi , W Arlt , RJ Ross , AM Isidori , JW Tomlinson

To read the full abstract: J Clin Endocrinol Metab. 2020; 105(1): dgz055. PMID: 31613957.Mineralocorticoid (MC) replacement therapy along with glucocorticoid (GC) replacement is crucial to avoid life-threating adrenal crises in Addison´s disease (AD) and in classical CAH (1–3). MC is administered with the aim of achieving plasma renin concentration (PRC) within the upper limit of ...